United States Biotechnology & Medical Research

Petros Pharmaceuticals Inc (PTPI)

Track

Petros Pharmaceuticals Inc has recorded no insider trading activity within the past three months. The most recent transactions occurred in late 2021, when John D. Shulman executed multiple purchase orders for company shares. These historical acquisitions represent the final documented movements by corporate insiders regarding equity holdings.
Ticker: PTPI Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Petros Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.8
SHULMAN JOHN D Non-Executive Director Large shareholder
Transaction date
Purchase
Price
198.13
Quantity 57,307 +25.5%
Value US$3,267,693
1.8
SHULMAN JOHN D Non-Executive Director Large shareholder
Transaction date
Purchase
Price
328.04
Quantity 54,273 +40.2%
Value US$2,598,109
1.8
SHULMAN JOHN D Non-Executive Director Large shareholder
Transaction date
Purchase
Price
362.21
Quantity 47,316 -39.7%
Value US$4,281,507
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-01-03 2021-12-22 B Purchase
1.8
SHULMAN JOHN D
Non-Executive Director Large shareholder
57,307 +25.5%
198.13
US$3,267,693 		57,307 +25.5% 198.13 US$3,267,693
2021-11-30 2021-11-29 B Purchase
1.8
SHULMAN JOHN D
Non-Executive Director Large shareholder
54,273 +40.2%
328.04
US$2,598,109 		54,273 +40.2% 328.04 US$2,598,109
2021-10-21 2021-10-18 B Purchase
1.8
SHULMAN JOHN D
Non-Executive Director Large shareholder
47,316 -39.7%
362.21
US$4,281,507 		47,316 -39.7% 362.21 US$4,281,507
Explore more

More insider trading research around Petros Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America